Natural products evaluated in neuropathic pain models - a systematic review

Basic and Clinical Pharmacology and Toxicology

Volumn 114, Issue 6, 2014, Pages 442-450

  Quintans, Jullyana S S ^a   Antoniolli, Ângelo R ^a   Almeida, Jackson R G S ^b   Santana Filho, Valter J ^a   Quintans Júnior, Lucindo J ^a,c  

^a FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^b UNIVERSIDADE FEDERAL DO VALE DO SÃO FRANCISCO   (Brazil)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTEOSIDE; ALKALOID DERIVATIVE; ALPHA AMYRIN; BETA AMYRIN; CANNABINOID; CAROTENOID; CARYOPHYLLENE; CURCUMIN; EPIGALLOCATECHIN GALLATE; EUPHOL; FLAVONOID; GELSENICINE; IRIDOID; KOUMINE; LAPPACONITINE; LINALOOL; LYCOPENE; MYRICETIN 3 RHAMNOSIDE; NATURAL PRODUCT; OPIATE DERIVATIVE; PHENOL DERIVATIVE; PUERARIN; QUERCETIN; RESVERATROL; SALVIANOLIC ACID B; SEROTONIN; STILBENE; TERPENE DERIVATIVE; TORMENTIC ACID; UNCLASSIFIED DRUG; UNINDEXED DRUG; ALKALOID; BIOLOGICAL PRODUCT; TERPENE;

ALCOHOLISM; ARTICLE; CHRONIC CONSTRICTION INJURY; CHRONIC PAIN; DRUG MECHANISM; DRUG SCREENING; DRUG TARGETING; HUMAN; NEUROPATHIC PAIN; NONHUMAN; PARTIAL SCIATIC NERVE LIGATION INJURY; PRIORITY JOURNAL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SYSTEMATIC REVIEW; ANIMAL; DISEASE MODEL; NEURALGIA; PHYTOTHERAPY;

ANIMALIA;

ALKALOIDS; ANIMALS; BIOLOGICAL PRODUCTS; DISEASE MODELS, ANIMAL; FLAVONOIDS; HUMANS; NEURALGIA; PHYTOTHERAPY; TERPENES;

EID: 84900021642     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/bcpt.12178     Document Type: Article

References (100)

1. +channel activation. J Ethnopharmacol 2010;128:567-74.
2. Hall GC, Carroll D, Parry D, Mcquay HJ. Epidemiology and treatment of neuropathic pain: the UK primary care perspective. Pain 2006;122:156-62.
3. Amin B, Hosseinzadeh H. Evaluation of aqueous and ethanolic extracts of saffron, Crocus sativus L., and its constituents, safranal and crocin in allodynia and hyperalgesia induced by chronic constriction injury model of neuropathic pain in rats. Fitoterapia 2012;83:888-95.
4. Saadé NE, Jabbur SJ. Nociceptive behavior in animal models for peripheral neuropathy: spinal and supraspinal mechanisms. Prog Neurobiol 2008;86:22-47.
5. Zimmermann M. Pathobiology of neuropathic pain. Eur J Pharmacol 2001;429:23-37.
6. Valsecchi AE, Franchi S, Panerai AE, Sacerdote P, Trovato AE, Colleoni M. Genistein, a natural phytoestrogen from soy, relieves neuropathic pain following chronic constriction sciatic nerve injury in mice: anti-inflammatory and antioxidant activity. J Neurochem 2008;107:230-40.
7. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353:1959-64.
8. Ji RR, Stricharstz G. Cell signaling and the genesis of neuropathic pain. Sci STKE 2004;252:reE14.
9. Besson JM. The neurobiology of pain. Lancet 1999;353:1610-5.
10. Ngo LT, Okogun JI, Folk WR. 21st Century natural product research and drug development and traditional medicines. Nat Prod Rep 2013;30:584-92.
11. Butler MS. Natural products to drugs: natural product derived compounds in clinical trials. Nat Prod Rep 2008;25:475-516.
12. Li JWH, Vederas JC. Drug discovery and natural products: end of an era or an endless frontier? Science 2009;325:161-5.
13. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264-9.
14. Barreiro EJ, Manssour CAM. Química Medicinal: As Bases Moleculares da Ação dos Fármacos. Art Med Editora Ltda, Porto Alegre, 2008;71-135.
15. Muthuraman A, Singh N. Attenuating effect of hydroalcoholic extract of Acorus calamus in vincristine-induced painful neuropathy in rats. J Nat Med 2011;65:480-7.
16. Garg G, Adams JD. Treatment of neuropathic pain with plant medicines. Chin J Integr Med 2012;18:565-70.
17. Mckeena D. Plant hallucinogens: springboards for psychotherapeutic drug discovery. Behav Brain Res 1996;73:109-15.
18. Raven PH. Medicinal plants and global sustainability: the canary in the coal mine. In: Medicinal Plants: A Global Heritage, Proceedings of the International Conference on Medicinal Plants for Survival New Delhi. International Development Research Center. 1998;14-8.
19. Kala CP, Dhyani PP, Sajwan BS. Developing the medicinal plants sector in northern India: challenges and opportunities. J Ethnobiol Ethnomed 2006;2:32-47.
20. Staud R. Effectiveness of CAM therapy: understanding the evidence. Rheum Dis Clin North Am 2011;37:9-17.
21. Roeder E, Wiedenfeld H. Plants containing pyrrolizidine alkaloids used in the traditional Indian medicine-including ayurveda. Pharmazie 2013;68:83-92.
22. Rajeswara BR, Syamasundar KV, Rajput DK, Nagaraju G, Adinarayana G. Biodiversity, conservation and cultivation of medicinal plants. J Pharmacog 2012;3:59-62.
23. Hoareau L, Dasilva E. Medicinal plants: a re-emerging health aid. Electronic J Biotechnol 1999;2:1-5.
24. Brandão MGL, Zanettia NNS, Oliveira P, Graelc CFF, Santos ACP, Monte-Móre RLM. Brazilian medicinal plants described by 19th century European naturalists and in the Official Pharmacopoeia. J Ethnopharmacol 2008;120:141-8.
25. Andersen OM, Markham KR. Flavonoids: Chemistry, Biochemistry and Applications. Taylor & Francis Group, Boca Raton, 2005;1254.
26. Grotewold E. The Science of Flavonoids. Springer, New York, 2006;273.
27. Havsteen BH. The biochemistry and medical significance of the flavonoids. Pharmacol Ther 2002;96:67-202.
28. Shahidi F, Janithaa PK, Wanasundara PD. Phenolic antioxidants. Crit Rev Food Sci Nutr 1992;32:67-103.
29. Nijveldt RJ, van Nood E, van Hoorn DE, Boelens PG, van Norren K, van Leeuwen PA. Flavonoids: a review of probable mechanisms of action and potential applications. Am J Clin Nutr 2001;74:418-25.
30. Le Marchand L. Cancer preventive effects of flavonoids - a review. Biomed Pharmacother 2002;56:296-301.
31. Pietta PG. Flavonoids as antioxidants. J Nat Prod 2000;63:1035.
32. Middleton E Jr, Kandaswami C. The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. In: Harborne JB (ed.). The Flavonoids: Advances in Research Since 1986. Chapman and Hall, London, 1994;619-52.
33. Bors W, Heller W, Michel C, Stettmaier K. Flavonoids and polyphenols: chemistry and biology In: Cadenas E, Packer L (eds). Handbook of Antioxidants. Marcel Dekker, New York, 1996;409-66.
34. Anjaneyulu M, Chopra K. Quercetin, a bioflavonoid, attenuates thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:1001-5.
35. Meotti FC, Missau FC, Ferreira J, Pizzolatti MG, Mizuzaki C, Nogueira CW et al. Anti-allodynic property of flavonoid myricitrin in models of persistent inflammatory and neuropathic pain in mice. Biochem Pharmacol 2006;72:1707-13.
36. Anjaneyulu M, Chopra K. Quercetin attenuates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rats. Indian J Exp Biol 2004;42:766-9.
37. (2+) channels. Eur J Pain 2010;14:992-8.
38. Murakami A, Tanaka T, Lee JY, Surh Y-J, Kim HW, Kawabata K et al. Zerumbone, a sesquiter-pene in subtropical ginger, suppresses skin tumor initiation and promotion stages in ICR mice. Int J Cancer 2004;110:481-90.
39. Grabmann J, Scheineider D, Weiser D, Elstner EF. Antioxidative effects of lemon oil and its components on copper induced oxidation of low density lipoprotein. Arzneimittelforschung 2001;51:799-805.
40. Grabmann J, Hippeli S, Spitzenberger R, Elstner EF. The monoterpene terpinolene from the oil of Pinus mugo L. in concert with a-tocopherol and b-carotene effectively prevents oxidation of LDL. Phytomedicine 2005;12:416-23.
41. De Sousa DP. Analgesic-like activity of essential oils constituents. Molecules 2011;16:2233-52.
42. Guimarães AG, Quintans JSS, Quintans LJ Jr. Monoterpenes with analgesic activity - a systematic review. Phytother Res 2013;27:1-15.
43. Batista PA, Werner MF, Oliveira EC, Burgos L, Pereira P, Brum LF et al. Evidence for the involvement of ionotropic glutamatergic receptors on the anti-nociceptive effect of (-)-linalool in mice. Neurosci Lett 2008;440:299-303.
44. Lima DF, Brandão MS, Moura JB, Leitão JM, Carvalho FA, Miúra LM et al. Antinociceptive activity of the monoterpene a-phellandrene in rodents: possible mechanisms of action. J Pharm Pharmacol 2012;64:283-92.
45. Sakurada T, Mizoguchi H, Kuwahata H, Katsuyama S, Komatsu T, Morrone LA et al. Intraplantar injection of bergamot essential oil induces peripheral antinoci-ception mediated by opioid mechanism. Pharmacol Biochem Behav 2001;97:436-43.
46. Mann J. Murder, Magic and Medicine. Oxford University Press, Oxford, 1992.
47. Wink M. (ed.). Plant secondary metabolites: biochemistry, function and biotechnology. In: Biochemistry of Plant Secondary Metabolism. Annual Plant Reviews. Sheffield Academic Press, New Delhi, 1999;1-16.
48. Xu Y, Qiu HQ, Liu H, Liu M, Huang ZY, Yang J et al. Effects of koumine, an alkaloid of Gelsemium elegans Benth., on inflammatory and neuropathic pain models and possible mechanism with allopregnanolone. Pharmacol Biochem Behav 2012;101:504-14.
49. Xu H, Arita H, Hayashida M, Zhang L, Sekiyama H, Hanaoka K. Pain-relieving effects of processed Aconiti tuber in CCI-neuropathic rats. J Ethnopharmacol 2006;103:392-7.
50. Hikino H, Ito T, Yamada C, Sato H, Konno C, Ohizumi Y. Analgesic principles of Aconitum roots. J Pharmacobiodyn 1979;2:78-83.
51. Murayama M, Mori T, Bando H, Amiya T. Studies on the constituents of Aconitum species. IX. The pharmacological properties of pyrotype aconitine alkaloids, components of the processed aconite powder 'kako-bushi-matsu': analgesic, anti-inflammatory, and acute toxic activities. J Ethnopharmacol 1991;35:159-64.
52. Suzuki Y, Hayakawa Y, Oyama T, Isono T, Ohmiya Y, Ikeda Y et al. Analgesic effect of benzoylmesaconine. Nihon Yakurigaku Zasshi 1993;102:399-404.
53. Ameri A. The effects of Aconitum alkaloids on the central nervous system. Prog Neurobiol 1998;56:211-35.
54. Taki M, Omiya Y, Suzuki Y, Ikeda Y, Noguchi M, Matsuba T et al. Quality and pharmacological investigation of processed Aconiti tuber (TJ-3022). Nat Med 1998;52:343-52.
55. Omiya Y, Goto K, Suzuki Y, Ishige A, Komatsu Y. Analgesia-producing mechanism of processed Aconiti tuber: role of dynorphin, an endogenous kappa-opioid ligand, in the rodent spinal cord. Jpn J Pharmacol 1999;79:295-301.
56. Sounvoravong S, Takahashi M, Nakashima MN, Nakashima K. Disability of development of tolerance to morphine and U-50, 488H, a selective kappa-opioid receptor agonist, in neuropathic pain model mice. J Pharmacol Sci 2004;3:305-12.
57. Mabley JG, Soriano FG. Role of nitrosative stress and poly (ADP-ribose) polymerase activation in diabetic vascular dys-function. Curr Vasc Pharmacol 2005;3:247-52.
58. Chung JM. The role of reactive oxygen species (ROS) in persistent pain. Mol Interventions 2004;4:248-50.
59. Drel VR, Pacher P, Vareniuk I, Pavlov I, Ilnytska O, Lyzogubov VV et al. A peroxynitrite decomposition catalyst counteracts sensory neuropathy in streptozotocin-diabetic mice. Eur J Pharmacol 2007;13:48-58.
60. Vincent AM, Brownlee M, Russell JW. Oxidative stress and pro-grammed cell death in diabetic neuropathy. Ann N Y Acad Sci 2002;959:368-83.
61. Wang ZQ, Porreca F, Cuzzocrea S, Galen K, Lightfoot R, Masini E et al. A newly identified role for superoxide in inflammatory pain. J Pharmacol Exp Ther 2004;309:869-78.
62. Kim JE, Kim AR, Chung HY, Han SY, Kim BS, Choi JS. In vitro peroxynitrite scavenging activity of diarylheptanoids from Curcuma longa. Phytother Res 2003;17:481-4.
63. Seltzer Z, Dubner R, Shir Y. A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain 1990;43:205-18.
64. Bennet GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 1998;188:87-107.
65. Basbaum AI. Distinct neurochemical features of acute and persistent pain. Proc Natl Acad Sci USA 1999;96:7739-43.
66. Petersen ZKR, Basbaum AI. Second messengers, the substantia gelatinosa and injury-induced persistent pain. Pain 1999; (Suppl 6):S5-12.
67. Urban MO, Gebhart GF. Supraspinal contributions to hyperalgesia. Proc Natl Acad Sci USA 1999;96:7687-92.
68. Mechoulam R. Marijuana: Chemistry, Pharmacology, Metabolism and Clinical Effects. Academic Press, New York, 1973;409.
69. Gertsch J, Leonti M, Raduner S, Racz I, Chen JZ, Xie K et al. β-caryophyllene is a dietary cannabinoid. Proc Natl Acad Sci USA 2008;105:9099-104.
70. Raduner S, Majewska A, Chen JZ, Xie XQ, Hamon J, Faller B et al. Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effects. J Biol Chem 2006;19:14192-206.
71. Raduner S, Bisson W, Abagyan R, Altmann KH, Gertsch J. Self-assembling cannabinomimetics: supramolecular structures of N-alkyl amides. J Nat Prod 2007;70:1010-5.
72. Malan TP Jr, Ibrahim MM, Deng H, Liu Q, Mata HP, Vanderah T et al. CB2 cannabinoid receptor-mediated peripheral antinociception. Pain 2001;93:239-45.
73. Ibrahim MM, Rude ML, Stagg NJ, Mata HP, Lai J, Vanderah TW et al. CB2 cannabinoid receptor mediation of antinociception. Pain 2006;122:36-42.
74. Hanus L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M et al. HU-308: a specific agonist of CB2 a peripheral cannabinoid receptor. Proc Natl Acad Sci USA 1999;96:14228-33.
75. Quartilho A, Mata HP, Ibrahim MM, Vanderah TW, Porreca F, Makriyannis A et al. Inhibition of inflammatory hyperalgesia by activation of peripheral CB2 cannnabinoid receptors. Anesthesiology 2003;99:955-60.
76. Clayton N, Marshall FH, Bountra C, O'shaughnessy CT. CB1 and CB2 cannabinoid receptors are implicated in inflammatory pain. Pain 2002;96:253-60.
77. Ibrahim MM, Deng H, Zvonok A, Cockayne DA, Kwan J, Mata HP et al. Activation of CB2 cannabinoid receptors by AM1241 inhibits experimental neuropathic pain: pain inhibition by receptors not present in the CNS. Proc Natl Acad Sci USA 2003;18:10529-33.
78. Nackley AG, Makriyannis A, Hohmann AG. Selective activation of cannabinoid CB2 receptors suppresses spinal fos protein expression and pain behavior in a rat model of inflammation. Neuroscience 2003;119:747-57.
79. Kissin I. The Development of new analgesics over the past 50 years: a lack of real breakthrough drugs. Anesth Analg 2010;110:780-9.
80. Bortalanza LB, Ferreira J, Hess SC, Delle Monache F, Yunes RA, Calixto JB. Anti-allodynic action of the tormentic acid, a triterpene isolated from plant, against neuropathic and inflammatory persistent pain in mice. Eur J Pharmacol 2002;453:203-8.
81. Sharma S, Anjaneyulu M, Kulkarni SK, Chopra K. Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats. Pharmacology 2006;76:69-75.
82. Sharma S, Kulkarni SK, Agrewala JN, Chopra K. Curcumin attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pharmacol 2006;536:256-61.
83. Costa B, Trovato AE, Comelli F, Giagnoni G, Colleoni M. The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain. Eur J Pharmacol 2007;556:75-83.
84. Sharma S, Kulkarni SK, Chopra K. Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Fundam Clin Pharmacol 2007;21:89-94.
85. Kuhad A, Chopra K. Lycopene ameliorates thermal hyperalgesia and cold allodynia in STZ-induced diabetic rat. Indian J Exp Biol 2008;46:108-11.
86. Kuhad A, Sharma S, Chopra K. Lycopene attenuates thermal hyperalgesia in a diabetic mouse model of neuropathic pain. Eur J Pain 2008;1:624-32.
87. Batista PA, Werner MF, Oliveira EC, Burgos L, Pereira P, Brum LF et al. The antinociceptive effect of (-)-linalool in models of chronic inflammatory and neuropathic hypersensitivity in mice. J Pain 2010;11:1222-9.
88. Silva KA, Paszcuk AF, Passos GF, Silva ES, Bento AF, Meotti FC et al. Activation of cannabinoid receptors by the pentacyclic triterpene α, β-amyrin inhibits inflammatory and neuropathic persistent pain in mice. Pain 2011;152:1872-87.
89. Tiwari V, Kuhad A, Chopra K. Amelioration of functional, biochemical and molecular deficits by epigallocatechin gallate in experimental model of alcoholic neuropathy. Eur J Pain 2011;15:286-92.
90. Isacchi B, Fabbri V, Galeotti N, Bergonzi MC, Karioti A, Ghelardini C et al. Salvianolic acid B and its liposomal formulations: anti-hyperalgesic activity in the treatment of neuropathic pain. Eur J Pharm Sci 2011;44:552-8.
91. Isacchi B, Iacopi R, Bergonzi MC, Ghelardini C, Galeotti N, Norcini M et al. Antihyperalgesic activity of verbascoside in two models of neuropathic pain. J Pharm Pharmacol 2011;63:594-601.
92. Liu M, Shen J, Liu H, Xu Y, Su YP, Yang J et al. Gelsenicine from Gelsemium elegans attenuates neuropathic and inflammatory pain in mice. Biol Pharm Bull 2011;34:1877-80.
93. Ou S, Zhao YD, Xiao Z, Wen HZ, Cui J, Ruan HZ. Effect of lappaconitine on neuropathic pain mediated by P2X3 receptor in rat dorsal root ganglion. Neurochem Int 2011;58:564-73.
94. Silva KA, Manjavachi MN, Paszcuk AF, Pivatto M, Viegas C Jr, Bolzani VS et al. Plant derived alkaloid (-)-cassine induces anti-inflammatory and anti-hyperalgesics effects in both acute and chronic inflammatory and neuropathic pain models. Neuropharmacology 2012;62:967-77.
95. Xu C, Xu W, Xu H, Xiong W, Gao Y, Li G et al. Role of puerarin in the signalling of neuropathic pain mediated by P2X(3) receptor of dorsal root ganglion neurons. Brain Res Bull 2012;87:37-43.
96. Dutra RC, Simão da Silva KA, Bento AF, Marcon R, Paszcuk AF, Meotti FC et al. Euphol, a tetracyclic triterpene produces antinociceptive effects in inflammatory and neuropathic pain: the involvement of cannabinoid system. Neuropharmacology 2012;63:593-605.
97. Quintão NL, Antonialli CS, da Silva GF, Rocha LW, de Souza MM, Malheiros A et al. Aleurites moluccana and its main active ingredient, the flavonoid 2′′-O-rhamnosylswertisin, have promising antinociceptive effects in experimental models of hypersensitivity in mice. Pharmacol Biochem Behav 2012;102:302-11.
98. Liu M, Zhou L, Chen Z, Hu C. Analgesic effect of iridoid glycosides from Paederia scandens (LOUR.) MERRILL (Rubiaceae) on spared nerve injury rat model of neuropathic pain. Pharmacol Biochem Behav 2012;102:465-70.
99. Kuwahata H, Katsuyama S, Komatsu T, Nakamura H, Corasaniti MT, Bagetta G et al. Local peripheral effects of β-caryophyllene through CB2 receptors in neuropathic pain in mice. Pharmacol Pharm 2012;3:397-403.
100. Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL. Neuroprotective effect of naringin by modulation of endogenous biomarkers in streptozotocin induced painful diabetic neuropathy. Fitoterapia 2012;83:650-9.